Health Outcomes Associated with Surgical Site Infections (SSI) in Solid Organ Transplant
PI: Trish M. Perl, MD, Msc & Eli Pernercivich, MD, MS; Sponsor: Centers for Disease Control and Prevention (CDC)

The goal of this study is to determine the risk factors and outcomes for SSI in solid organ transplants. To that end, we aim to have a complete 2-year cohort of all solid organ transplants completed by 12/01/2002. Transplant surgery patients are followed for 60 days for SSI. All patients who have had solid organ transplants from 10/01/2000 to 9/30/2002 will be entered into the cohort. The infection control service has been doing prospective surveillance at UMMS for infections in kidney and pancreas transplants from 10/01/2000 to present. Transplants preformed and subsequent infections have been documented through prospective surveillance.Analysis will begin in the spring 2003 with aim to complete full analysis fall 2003.

Additionally, we have begun to examine this study for possible adaptation to the CDC Prevention Epicenters Program. As part of this program, we would alter the study, making it able to be done at 6 other institutions. This collaboration will enable us to collect valuable information on SSI in SOT from other comparable institutions throughout the country, increasing our knowledge base and predictive value. Collaboration with the CDC is currently being discussed.

• Top of Page
• Back to Current Studies